7 results
Management of Diabetes Mellitus in Patients With CKD

1. Monitor for changes in BP, serum creatinine, &
for changes in BP ... initiation of treatment ... ADA/KDIGO Consensus ... agreed by health care ... evidence-based pharmacologic
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... suspension 400 mg PO BID ... Systemic antifungals are ... candida #mucosal #IDSA ... infections #HIVAIDS #pharmacology
Lithium Therapy for Bipolar Disorder 
Toxicity Levels: 
 - Mild (1-1.5 mEq/L) 
 - Moderate (1.6-2.5
maintenance agent for treatment ... If levels are high ... , patients are at ... Bipolar #Disorder #BPD ... #Toxicity #Pharmacology
Alcohol Use Disorder - Maintenance Treatment
Naltrexone (first line) - First line for most people without contraindications
- Maintenance Treatment ... Dosing: Goal 150 mg BID ... TID Acamprosate (FDA ... TID Disulfiram (FDA ... #management #pharmacology
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
IDSA Recommendations ... concentrations are ... Valganciclovir 900 mg PO BID ... Cytomegalovirus #CMV #IDSA ... infections #HIVAIDS #pharmacology
Eosinophilic Esophagitis (EoE) - Topical Corticosteroids
 • Liquid - Budesonide - 1 mg PO BID -
Budesonide - 1 mg PO BID ... off-label use, FDA ... formulations for treatment ... of EOE are currently ... Corticosteroids #management #pharmacology
Management of Anthracyclines and HER2 Antagonist Cardiotoxicity
Anthracyclines cause cardiomyopathy:
 ✖ Reduction in left ventricular ejection fraction
to HER2 agents are ... ) and initiate treatment ... Lapatinib, Pertuzumab, Ado-trastuzumab ... cardiology #oncology #pharmacology ... #toxicity #chemotherapy